|
Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1104
|
$1.02T |
16.5x |
37.2x |
|
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$208
|
$527B |
5.7x |
14.9x |
|
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$228
|
$465B |
7.7x |
18.2x |
|
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 314
|
$336B |
4.4x |
11.1x |
|
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£141
|
$312B |
5.4x |
15.5x |
|
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$105
|
$283B |
4.4x |
9.8x |
|
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 105
|
$272B |
4.9x |
12.0x |
|
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$345
|
$231B |
6.4x |
12.7x |
|
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 300
|
$217B |
4.6x |
9.4x |
|
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$26
|
$192B |
3.1x |
7.7x |
|
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$128
|
$176B |
6.0x |
11.3x |
|
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$49
|
$135B |
2.8x |
7.7x |
|
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€86
|
$129B |
2.5x |
8.3x |
|
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£18
|
$114B |
2.7x |
7.9x |
|
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$432
|
$105B |
8.8x |
21.2x |
|
Chugai Pharmaceutical Co
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 8564
|
$84.6B |
10.7x |
21.0x |
|
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€31
|
$72.7B |
1.4x |
6.6x |
|
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4535
|
$70.9B |
2.4x |
9.1x |
|
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€115
|
$68.6B |
2.8x |
9.8x |
|
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 183
|
$66.8B |
4.2x |
12.6x |
|
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$128
|
$61.5B |
6.5x |
15.0x |
|
Jiangsu Hengrui Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 63
|
$52.9B |
11.4x |
38.0x |
|
Jiangsu Hengrui Pharma
|
Hong Kong |
Biopharmaceuticals
|
HKD 69
|
$52.8B |
11.4x |
38.1x |
|
Lonza Group
|
Switzerland |
Contract Research & Manufacturing,
Biopharmaceuticals
|
CHF 541
|
$51.5B |
5.6x |
19.0x |
|
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1805
|
$45.9B |
7.3x |
25.7x |
|
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 86
|
$44.8B |
2.6x |
8.9x |
|
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3862
|
$43.2B |
3.3x |
16.2x |
|
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 56
|
$34.2B |
3.1x |
14.3x |
|
Celltrion
|
South Korea |
Biopharmaceuticals
|
KRW 187400
|
$30.0B |
10.8x |
31.1x |
|
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$182
|
$29.3B |
3.0x |
9.6x |
|
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 9027
|
$28.6B |
1.9x |
7.7x |
|
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 40
|
$27.2B |
13.3x |
35.8x |
|
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$11
|
$25.8B |
1.8x |
6.2x |
|
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1983
|
$25.6B |
2.0x |
8.9x |
|
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$40
|
$24.2B |
8.1x |
8.5x |
|
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 388
|
$22.3B |
63.0x |
41.7x |
|
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 9
|
$22.0B |
2.2x |
6.3x |
|
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 95
|
$20.0B |
11.0x |
82.5x |
|
Alteogen
|
South Korea |
Biopharmaceuticals
|
KRW 518000
|
$18.6B |
128.0x |
244.0x |
|
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€9
|
$16.9B |
2.0x |
8.0x |
|
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 2002
|
$15.8B |
4.4x |
11.6x |
|
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 7
|
$15.2B |
3.3x |
12.2x |
|
Torrent Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 3756
|
$14.5B |
10.3x |
31.4x |
|
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$152
|
$14.4B |
5.1x |
21.7x |
|
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€51
|
$14.3B |
4.8x |
12.8x |
|
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 121
|
$13.9B |
30.5x |
-1001.8x |
|
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 339
|
$13.6B |
4.6x |
12.0x |
|
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 26
|
$13.0B |
2.2x |
12.7x |
|
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 453
|
$13.0B |
46.9x |
-272.6x |
|
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1523
|
$12.7B |
3.9x |
16.2x |
|
Yunnan Baiyao Group
|
China |
Biopharmaceuticals,
Health & Beauty
|
CNY 56
|
$12.3B |
2.1x |
14.4x |
|
CR Pharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics,
Pharmacies
|
HKD 5
|
$11.8B |
0.3x |
5.3x |
|
Ipsen
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€128
|
$11.5B |
2.7x |
7.1x |
|
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1248
|
$11.5B |
3.1x |
12.3x |
|
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 2760
|
$11.4B |
3.7x |
9.3x |
|
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2259
|
$11.0B |
7.1x |
28.4x |
|
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 940
|
$10.8B |
3.9x |
13.9x |
|
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 2072
|
$10.5B |
3.8x |
15.0x |
|
Financiere de Tubize
|
Belgium |
Biopharmaceuticals
|
€204
|
$10.5B |
N/A |
N/A |
|
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 8
|
$10.4B |
2.6x |
10.5x |
|
Wuxi XDC
|
Hong Kong |
Contract Research & Manufacturing,
Biopharmaceuticals
|
HKD 67
|
$10.3B |
12.5x |
39.8x |
|
Zhejiang NHU
|
China |
Biopharmaceuticals,
Nutraceuticals & Cosmeceuticals
|
CNY 24
|
$10.2B |
3.1x |
7.4x |
|
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$8
|
$10.2B |
1.6x |
5.3x |
|
Orion
|
Finland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€61
|
$10.0B |
4.7x |
12.7x |
|
Huadong Medicine
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 41
|
$10.0B |
1.6x |
12.6x |
|
Abivax
|
France |
Drug Development & Therapeutics,
Biopharmaceuticals
|
€108
|
$9.8B |
1006.0x |
-46.0x |
|
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$73
|
$9.4B |
7.1x |
10.9x |
|
3SBio
|
Hong Kong |
Biopharmaceuticals
|
HKD 32
|
$9.0B |
3.6x |
5.6x |
|
Eisai Co.
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 5031
|
$8.7B |
1.7x |
13.6x |
|
Hebei Changshan
|
China |
Biopharmaceuticals
|
CNY 63
|
$8.5B |
N/A |
N/A |
|
Aurobindo Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1227
|
$7.8B |
2.1x |
10.4x |
|
Lundbeck
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 41
|
$7.7B |
N/A |
N/A |
|
Alkem Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 5773
|
$7.4B |
4.7x |
23.7x |
|
Kyowa Kirin Co
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2654
|
$7.4B |
2.4x |
10.6x |
|
Biocon
|
India |
Biopharmaceuticals,
Contract Research & Manufacturing
|
INR 399
|
$7.1B |
3.8x |
18.2x |
|
RemeGen
|
Hong Kong |
Biopharmaceuticals
|
HKD 95
|
$7.0B |
18.2x |
-464.3x |
|
Abbott India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Nutraceuticals & Cosmeceuticals
|
INR 30024
|
$6.9B |
9.1x |
33.6x |
|
Krka
|
Slovenia |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€204
|
$6.5B |
2.8x |
10.3x |
|
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$13
|
$6.4B |
2.1x |
9.5x |
|
Shanghai RAAS
|
China |
Biopharmaceuticals
|
CNY 7
|
$6.3B |
5.5x |
18.5x |
|
China Resources Sanjiu
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 29
|
$6.3B |
1.5x |
8.2x |
|
Ono Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2169
|
$6.2B |
2.0x |
8.2x |
|
Yuhan
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics
|
KRW 119201
|
$6.1B |
4.0x |
47.4x |
|
Hikma Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£16
|
$6.0B |
1.8x |
7.1x |
|
Cogent Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$40
|
$6.0B |
N/A |
-22.6x |
|
Glenmark Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1921
|
$5.9B |
3.5x |
19.1x |
|
Imeik Technology Development
|
China |
Biopharmaceuticals
|
CNY 145
|
$5.8B |
15.6x |
23.3x |
|
ABL Bio
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics
|
KRW 173400
|
$5.7B |
84.7x |
-707.3x |
|
Dottikon ES Holding
|
Switzerland |
Chemicals,
Biopharmaceuticals
|
CHF 324
|
$5.4B |
N/A |
N/A |
|
Changchun High-Tech
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 100
|
$5.4B |
2.8x |
11.0x |
|
PharmaEssentia
|
Taiwan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
TWD 504
|
$5.3B |
11.2x |
34.8x |
|
Henlius Biotech
|
Hong Kong |
Biopharmaceuticals
|
HKD 68
|
$5.2B |
6.1x |
27.8x |
|
Gedeon Richter
|
Hungary |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HUF 9800
|
$5.0B |
1.8x |
4.9x |
|
Peptron
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics,
Drug Delivery Systems
|
KRW 319000
|
$5.0B |
N/A |
N/A |
|
Gan and Lee
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 63
|
$4.9B |
8.5x |
26.3x |
|
Shanghai Junshi
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 37
|
$4.8B |
13.7x |
-70.9x |
|
Beijing Tiantan
|
China |
Biopharmaceuticals
|
CNY 18
|
$4.7B |
4.9x |
13.1x |
|
Bachem
|
Switzerland |
Chemicals,
Biopharmaceuticals
|
CHF 51
|
$4.6B |
5.5x |
19.3x |
|
ADMA Biologics
|
United States of America |
Biopharmaceuticals
|
$19
|
$4.6B |
9.1x |
20.1x |
|
Celcuity
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$100
|
$4.5B |
N/A |
-28.0x |